Clinical Trials Logo

Acute Gouty Arthritis Flares clinical trials

View clinical trials related to Acute Gouty Arthritis Flares.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01470989 Completed - Clinical trials for Acute Gouty Arthritis Flares

β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)

ß-RELIEVED
Start date: November 2011
Phase: Phase 3
Study type: Interventional

This was an 18-month, multi-center, open-label, clinical extension study. Patients completing earlier second extension studies (CACZ885H2356E2 and CACZ885H2357E2) continued to be treated in this combined extension 3 study for any new gouty arthritis flare on demand with one subcutaneous (s.c.) injection of canakinumab 150 mg.